A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use. © Ivyspring International Publisher.
Allogeneic stem cell transplantation for metastatic renal cell cancer (RCC) / Bregni, M.; Ciceri, F.; Peccatori, J.. - In: JOURNAL OF CANCER. - ISSN 1837-9664. - 2:1(2011), pp. 347-349. [10.7150/jca.2.347]
Allogeneic stem cell transplantation for metastatic renal cell cancer (RCC)
Ciceri F.Secondo
;
2011-01-01
Abstract
A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use. © Ivyspring International Publisher.| File | Dimensione | Formato | |
|---|---|---|---|
|
v02p0347.pdf
accesso aperto
Tipologia:
PDF editoriale (versione pubblicata dall'editore)
Licenza:
Creative commons
Dimensione
349.14 kB
Formato
Adobe PDF
|
349.14 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
